News from other sources...
Medicare still lagging behind on telehealth | Medscape
Medicare has long been criticized for its narrow restrictions on the coverage and reimbursement of telehealth services. A new report to Congress by the U.S. Government Accountability Office shows that not much has changed over the years.
Medical devices and equipment
The Indiana-based medical device company that got Tom Price into hot water as a nominee for his current position, Secretary of Health and Human Services, would benefit greatly from a new Medicare payment proposal.
Not-for-profit linked to PhRma rolls out campaign to block drug imports | Kaiser Health News
A nonprofit organization that has orchestrated a wide-reaching campaign against foreign drug imports has deep ties to the Pharmaceutical Research and Manufacturers of America, or PhRMA, the powerhouse lobbying group that includes Eli Lilly, Pfizer and Bayer.
Kids with Hepatitis C get new drugs and coverage may prove easier than for adults | Kaiser Health News
With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic have a better chance at a cure. Kids may have an easier time than adults getting treatment approved, some experts say.
Defiant, generic drug maker continues to raise prices | The New York Times
Congressional hearings. Federal investigations. Consumer outrage. In the wake of developments like these, many drug company executives are laying low. Not Arthur P. Bedrosian, chief executive of Lannett Company.
In a summit full of addiction experts, each looking for the next big solution to curb opioid abuse, everything from treatment policies to the containers holding prescription pills are being considered.
One of the world's most pressing global health stories has long been hiding in plain sight — the devastating shortage of surgeons in many countries around the world.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.